Non-GAAP EPS guidance was chopped 19%, to between $13.02 and $13.52 from between $16.10 and $16.60
Prior authorization is a more restrictive type of cost-management strategy, in that every prescription will be stopped at point of sale and may require a physician to confirm that the drug is being prescribed for those with diabetes or possibly provide documentation of medical records showing a blood glycemic level test (e.g., A1C) that confirms diabetes
Each Wegovy pen contains a single dose strength, reducing the risk of selecting an incorrect dose
Participants lost an average of 36.6 lbs on the highest dose, with A1C reduced by 1.72.0 percentage points
This creates a more complete treatment mix that: Supports energy levels and prevents fatigue, which can be a challenge when appetite decreases Enhances metabolic function, helping your body burn calories more efficiently Promotes smoother tolerance and may reduce side effects like nausea Additional Medical Weight Loss Support Prescription medications For patients who may not qualify for GLP-1s, non-GLP-1 appetite suppressants and other physician-guided medications may be recommended
